ZYDUSLIFE
Zydus Lifesciences Limited
Pharmaceuticals
Share price
₹1,160
Market cap
₹1.2L Cr
1Y return
▲ 17%
A vertically integrated pharmaceutical company, Zydus Lifesciences develops, manufactures, and markets generic drugs, specialty pharmaceuticals, and biologics for domestic and international markets. The company operates across multiple therapeutic areas including cardiology, gastroenterology, oncology, and immunology. It serves patients globally through its extensive distribution network, research capabilities, and commitment to addressing unmet healthcare needs across diverse populations and geographies.
Investors holding Zydus Lifesciences Limited
5.41%
Recent moves 4
Prashant Babubhai Patel
19 Aug 2026. Sign in to see this move
LICDecreased
LIC decreased its stake in Zydus Lifesciences from 5.56% to 5.41%, selling 19.37 lakh shares for ₹224.50 Cr at ₹1159.00 apiece.
Read more
Kotak Mutual FundIncreased
Kotak Mutual Fund increased its stake in Zydus Lifesciences from 1.13% to 1.19%, raising its shareholding from 1,13,97,485 to 1,19,11,788 shares.
Read more
PPFAS Mutual FundIncreased
PPFAS Mutual Fund increased its stake in Zydus Lifesciences from 1.96% to 2.02%, acquiring 471,413 additional shares. This change reflects an increased position in the company.
Read more
Track the whales in Zydus Lifesciences Limited
Get alerted the moment a top investor buys or sells.
Get started